Biomarkable

From Concept to Value – Hugo Vanderstichele

Main menu

Skip to primary content
Skip to secondary content
  • About
    • The Founder
  • News
  • Our Mission
  • The Approach
  • Development
    • Assay development
    • Development Plan
    • Product Requirements
  • References
    • Acknowledgements
    • Comments
    • Publications
      • Overview
      • Cardiovascular diseases
      • Embryogenesis
      • Endocrinology
      • Neurodegeneration
      • Neurotoxicity
  • Links
  • Contact

2013, 2 May, A new paper related to the evaluation of variability in CSF biomarker testing was published.

2013, 2 May, A new paper related to the evaluation of variability in CSF biomarker testing was published.

Posted on 2 May, 2013 by admin

The founder contributed to a new paper in Alzheimer’s & Dementia, entitled ” CSF biomarker variability in the Alzheimer’s Association quality control program”. 

Read more ….

 2013-Mattsson-Alz Dem - QC program

This entry was posted in Publications, validation. Bookmark the permalink.

Post navigation

← Previous Next →

Contact Us

Tuinwijklaan 43 - 9000 Gent - Belgium

Recent News

  • Alzforum News on Blood test 4 February, 2019
© 2013 All Rights Reserved Biomarkable.